Toward Individualized Management: A Commentary on Perioperative Systemic Therapy Guidelines in Breast Cancer Surgery and Reconstruction. Comment on Galuia et al. Perioperative Drug Management of Systemic Therapies in Breast Cancer: A Literature Review and Treatment Recommendations. Curr. Oncol. 2025, 32, 154

Read full text
Authors: Emily E. Zona, Jacqueline S. Israel
Cited by: 1
References: 7

Abstract

The perioperative management of systemic breast cancer therapies is an increasingly important aspect of planning for breast cancer surgery and reconstruction. This commentary compares two recent sets of recommendations and explains why treatment decisions often need to be tailored to the individual patient. By highlighting differences in methodology and clinical considerations, we emphasize the importance of individualized perioperative planning and close collaboration between surgeons and oncologists. Continued research will help refine these strategies and improve care for patients undergoing breast reconstruction.

Fields of Study & Subjects

Cancer Stress Anesthesia and Immune Response Breast Cancer Treatment Studies Lymphatic System and Diseases

Publication details

Journal / source
Current Oncology
Publisher
MDPI AG
Volume
33
Issue
5
Pages
294–294
Publication date
19 May 2026
Language
EN